ARWR earnings date and last-quarter result: last quarter beat, P/E -41.45. Updated 2026-07-23.
Arrowhead Pharmaceuticals (ARWR) Research Hub
Arrowhead Pharmaceuticals (ARWR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 58.98 USD (+1.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -41.45, market cap 12.70B. This hub links to the full technical, earnings and options research available for ARWR.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 58.98 USD (+1.65%) |
| 52-week range | 55.83 USD – 95.49 USD |
| Trend regime | Range |
| 14-day RSI | 41.6 (Bearish) |
| Trailing P/E | -41.45 |
| Market cap | 12.70B |
| Dividend yield | 0.00% |
Available research for ARWR
Covered Call on ARWR: how it works, illustrative setup around the real 58.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ARWR: how it works, illustrative setup around the real 58.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ARWR: how it works, illustrative setup around the real 58.98 USD price, max profit/loss, breakeven and when to use it. Educational.
ARWR technical analysis: range, last 58.98 USD, RSI 41.6, 52w range 55.83 USD–95.49 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ARWR in?
Arrowhead Pharmaceuticals (ARWR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ARWR in an uptrend or downtrend?
As of 2026-10-26, ARWR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ARWR's trailing P/E ratio?
ARWR's trailing P/E is -41.45, with a market cap of 12.70B. See the earnings research page for full valuation detail.